{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T17:24:42Z","timestamp":1779902682756,"version":"3.53.1"},"reference-count":15,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T00:00:00Z","timestamp":1606348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p><jats:bold>Objectives:<\/jats:bold> Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis and sporadic Creutzfeldt\u2013Jakob disease (sCJD) share similar clinical features. Here, we present two unusual cases of anti-NMDAR encephalitis who were misdiagnosed as sCJD at first.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> We described two patients' clinical manifestations, as well as the string of symptomatological evolution, treatments, and follow-up results.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Our patients presented with rapidly progressive dementia, memory problems, psychiatric symptoms, and movement disorders, and we considered all these symptoms as a presenting feature of sCJD at first, but the cerebrospinal fluid examination showed positive results for both the 14-3-3 protein and antibodies against NMDAR. Immunomodulatory treatment led to a resolution of these deficits, and both of them remained in remission after treatment.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> Anti-NMDAR encephalitis can present with rapidly progressive cognitive decline, and sometimes laboratory investigations can be misleading. The examination for the presence of NMDAR antibodies is necessary, even with the presence of 14-3-3 protein. Early immunomodulatory therapy should be considered, especially for patients with high titers of NMDAR antibodies.<\/jats:p>","DOI":"10.3389\/fneur.2020.593680","type":"journal-article","created":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T07:08:04Z","timestamp":1606374484000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Anti-N-methyl-D-Aspartate Receptor Encephalitis Mimicking Sporadic Creutzfeldt\u2013Jakob Disease"],"prefix":"10.3389","volume":"11","author":[{"given":"Jiao","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huifang","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,11,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/ana.21050","article-title":"Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma","volume":"61","author":"Dalmau","year":"2007","journal-title":"Ann Neurol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jneuroim.2012.06.010","article-title":"Antibodies to N-methyl-D-aspartate glutamate receptors in Creutzfeldt-Jakob disease patients","volume":"251","author":"Fujita","year":"2012","journal-title":"J Neuroimmunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1007\/s00415-012-6489-3","article-title":"NMDA receptor autoantibodies in sporadic Creutzfeldt-Jakob disease","volume":"259","author":"Mackay","year":"2012","journal-title":"J Neurol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1001\/jamaneurol.2013.2077","article-title":"Autoantibodies in sporadic Creutzfeldt-Jakob disease","volume":"70","author":"Angus-Leppan","year":"2013","journal-title":"JAMA Neurol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"881","DOI":"10.4065\/mcp.2010.0326","article-title":"Autoimmune dementia: clinical course and predictors of immunotherapy response","volume":"85","author":"Flanagan","year":"2010","journal-title":"Mayo Clin Proc"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1001\/archneur.65.10.1341","article-title":"Voltage-gated potassium channel autoimmunity mimicking creutzfeldt-jakob disease","volume":"65","author":"Geschwind","year":"2008","journal-title":"Arch Neurol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1001\/jamaneurol.2013.4857","volume":"71","author":"Grau-Rivera","year":"2014","journal-title":"JAMA Neurol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1007\/s00415-011-6291-7","article-title":"Detection of anti-glutamate receptor epsilon2 and anti-N-methyl-D: -aspartate receptor antibodies in a patient with sporadic Creutzfeldt-Jakob disease","volume":"259","author":"Fujita","year":"2012","journal-title":"J Neurol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e178","DOI":"10.1212\/NXI.0000000000000178","article-title":"Pathologically confirmed autoimmune encephalitis in suspected Creutzfeldt-Jakob disease","volume":"2","author":"Maat","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B10","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1136\/jnnp-2014-308695","article-title":"Neuronal antibodies in patients with suspected or confirmed sporadic Creutzfeldt-Jakob disease","volume":"86","author":"Rossi","year":"2015","journal-title":"J Neurol Neurosurg Psychiatr."},{"key":"B11","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1212\/WNL.0b013e31826d5fc3","article-title":"Evidence-based guideline: diagnostic accuracy of CSF 14-3-3 protein in sporadic Creutzfeldt-Jakob disease: report of the guideline development subcommittee of the American academy of neurology","volume":"79","author":"Muayqil","year":"2012","journal-title":"Neurology"},{"key":"B13","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1002\/1531-8249(199911)46:5&<774::AID-ANA14>3.0.CO;2-N","article-title":"Detection of 14-3-3 brain protein in the cerebrospinal fluid of patients with paraneoplastic neurological disorders","volume":"46","author":"Saiz","year":"1999","journal-title":"Ann Neurol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1136\/practneurol-2018-001935","article-title":"RT-QuIC: a new test for sporadic CJD","volume":"19","author":"Green","year":"2019","journal-title":"Pract Neurol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.jocn.2018.01.064","article-title":"CSF Tau supplements 14-3-3 protein detection for sporadic Creutzfeldt-Jakob disease diagnosis while transitioning to next generation diagnostics","volume":"50","author":"Li","year":"2018","journal-title":"J Clin Neurosci"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2020.593680\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T07:08:05Z","timestamp":1606374485000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2020.593680\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,26]]},"references-count":15,"alternative-id":["10.3389\/fneur.2020.593680"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2020.593680","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,26]]},"article-number":"593680"}}